Wockhardt shares on December 1 jumped 19% after the US FDA accepted the company’s New Drug Application for Zaynich, its first-in-class antibiotic. But the rally cooled over the next two days as investors booked profits, leading to back-to-back 5% drops.
Is the smallcap rally a trap? Only 37% of stocks are outperforming their benchmark
India’s recent smallcap surge indicates that less stock is outpacing the benchmark index, revealing a narrowing group of successful stocks boosting overall returns. Conversely, largecap
August 25, 2026